Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2017. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3332463012 | Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3332485018 | Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3333577019 | R-ICE chemotherapy regimen | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3334372019 | R-ICE chemotherapy protocol | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 3925471000052115 | R-ICE-cytostatikaregim | sv | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Is a | Antineoplastic chemotherapy regimen (regime/therapy) | true | Inferred relationship | Some | ||
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Method | Administration - action | true | Inferred relationship | Some | 4 | |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Direct substance | Ifosfamide (substance) | true | Inferred relationship | Some | 4 | |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Method | Administration - action | true | Inferred relationship | Some | 5 | |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Method | Administration - action | true | Inferred relationship | Some | 6 | |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Method | Administration - action | true | Inferred relationship | Some | 7 | |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Direct substance | Etoposide (substance) | true | Inferred relationship | Some | 5 | |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Direct substance | Rituximab (substance) | true | Inferred relationship | Some | 7 | |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Direct substance | Carboplatin (substance) | true | Inferred relationship | Some | 6 | |
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Is a | Rituximab therapy (procedure) | true | Inferred relationship | Some | ||
| Rituximab, ifosfamide, carboplatin and etoposide chemotherapy regimen (regime/therapy) | Has intent | Therapeutic | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR